Your session is about to expire
← Back to Search
Behavioral Intervention
Telemental Health Intervention for Dementia Caregivers (TMH Pilot Trial)
N/A
Waitlist Available
Led By Cory K. Chen, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post treatment, an average of 12-18 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will develop and test an assessment and treatment strategy to help family caregivers of people with dementia who are struggling with interpersonal skills.
Who is the study for?
This trial is for family or friend caregivers who provide at least 4 hours of daily care to a person with dementia. One of them must be a Veteran. The caregiver should not be receiving the REACH VA protocol and must help someone with documented dementia, who can respond to instructions and has behavioral problems.
What is being tested?
The study is testing a new telemental health intervention designed to improve interpersonal skills between caregivers and persons with dementia (PWD). It includes video assessments by clinicians and subsequent family therapy tailored to identified challenges.
What are the potential side effects?
Since this trial involves psychological assessment and therapy, there may not be physical side effects like in drug trials. However, participants might experience emotional discomfort or stress during the process.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post treatment, an average of 12-18 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post treatment, an average of 12-18 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Healthy Aging Brain Center Monitor (HABC Monitor)
Secondary study objectives
Patient Health Questionnaire - 9 (PHQ)
The Kansas Marital Conflict Scale (KMCS)
Zarit Burden Scale
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Intervention GroupExperimental Treatment1 Intervention
Caregiver and patient with dementia dyads who receive the family intervention.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,765,846 Total Patients Enrolled
Cory K. Chen, PhDPrincipal InvestigatorManhattan Campus of the VA NY Harbor Healthcare System, New York, NY
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The caregiver has serious problems with thinking and memory.The person taking care of you has a mental illness called psychosis.The person taking care of the participant can't meet the study requirements.The person needing care must have an official diagnosis of dementia.The person taking care of you must say that you have troubling behavior issues.The person being cared for must have difficulty with memory or thinking based on a test or a doctor's diagnosis.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.